Loading...
Adverse effects of antipsychotic medication in patients with 22q11.2 deletion syndrome: A systematic review
The 22q11.2 deletion syndrome (22q11.2DS) is a multisystem condition and the most prevalent microdeletion syndrome in humans. Approximately 25% of individuals with 22q11.2DS receive antipsychotic treatment. To assess whether patients with 22q11.2DS are vulnerable to adverse effects of antipsychotic...
Na minha lista:
| Udgivet i: | Am J Med Genet A |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6851664/ https://ncbi.nlm.nih.gov/pubmed/31407842 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajmg.a.61324 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|